Answers are grounded in this paper and cite their sources.
The accumulation of cyclic adenosine 3',5'-monophosphate (cyclic AMP) was determined by measuring the accumulation of labeled cyclic AMP in fat cells whose adenine nucleotides had been labeled with adenine-3H during the isolation of the white adipose cells. The addition of growth hormone and 9α-fluoro-11β,17α,21-trihydroxy-16α-methyl-pregna-1, 4-diene-3,20-dione (dexamethasone) increased the accumulation of labeled cyclic AMP and lipolysis after a lag period of at least 1 hour. At the end of 4 hours of incubation, most of the increase in accumulation of cyclic AMP due to epinephrine or growth hormone and dexamethasone was in the medium rather than in the cells. Puromycin and cycloheximide, which are inhibitors of protein synthesis, blocked the increases in both labeled cyclic AMP accumulation and lipolysis due to growth hormone and dexamethasone. However, the addition of cycloheximide alone did stimulate cyclic AMP accumulation without affecting lipolysis due to theophylline. Growth hormone and glucocorticoid also increased phosphorylase activity in fat cells, and this was blocked by cycloheximide. These results indicate that there is an increase in accumulation of labeled cyclic AMP due to growth hormone and glucocorticoid which is blocked by inhibitors of protein synthesis.
No takes yet. Share an insight, caveat, or question.
Moskowitz et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: